Neuroscience Researcher Has Positive Message for International Alzheimer's Awareness Week, July 6 - 12: 'Even Though World Economy is Declining, Alzheimer's Research is Advancing'
MADISON, Wis., July 7 /PRNewswire/ -- In the midst of generally gloomy worldwide economic news and rising global tensions, an American neuroscience researcher has
a message of hope: The answer for Alzheimer's disease and other degenerative diseases of the brain that cause memory loss may be much ...
Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
LEXINGTON, Massachusetts, July 6 /PRNewswire-FirstCall/ -- Shire plc
(LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company,
announces that, at the request of the FDA, in view of a potential restriction
on the availability of the current approved and marketed treatment fo...
Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines
RECORD trial also demonstrates durable blood sugar control over time with Avandia
LONDON, RESEARCH TRIANGLE PARK, N.C., and NEW ORLEANS, June 5 /PRNewswire/ -- Clinical trial results presented today at the American Diabetes Association annual meeting show that overall rates of cardiovascular ...
Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
Randomized, Controlled, Multicenter Trial Will Test Ability of Adecatumumab to Prolong Disease Free Survival in High Risk Patients with Liver Metastases
BETHESDA, Md., March 23 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, propriet...
Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment
HONOLULU, Jan. 28 /PRNewswire/ -- Results of a pre-clinical study of
leconotide, an investigative calcium channel blocker, shows it has
potential to be safe, selective, and efficacious as a new non-opioid treatment
for pain relief. It also holds promise in multiple drug delivery options
Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
CARLSBAD, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals,
Inc. (Nasdaq: ISIS ) announced today that OncoGenex Pharmaceuticals, Inc.
provided positive survival results from a randomized Phase 2 clinical trial of
OGX-011 in combination with docetaxel and prednisone ("the OGX-011 arm...
German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008
GÃ¿RLITZ, Germany, November 28 /PRNewswire/ -- German biotech company
Partec is expanding its global leadership in specialized HIV monitoring and
AIDS patient follow-up diagnostics for developing and emerging countries. In
the year 2008, 2.5 million patient tests have been performed with the
New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults
SAN FRANCISCO, Nov. 19 /PRNewswire/ -- Posit Science Corporation
researcher, Dan Tinker, presented evidence at the Society for Neuroscience
Annual Conference in Washington, DC this week indicating that cognitive
training may benefit Baby Boomers. The computerized brain plasticity-based
SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
FRESNO, Calif., Oct. 29 /PRNewswire/ -- Cypress Systems, Inc., a Fresno
CA based biotechnology company, emphasizes that the SELECT TRIAL results --
that were announced yesterday -- used a form of selenium known as
selenomethionine. The SELECT TRIAL found no effects of either
Concord Grape Juice Has No Significant Impact on Body Weight
Recent study revealed that drinking polyphenol-rich 100% Concord grape
juice was not associated with changes in appetite, energy intake or body
CONCORD, Mass., Oct. 6 /PRNewswire/ -- Regular consumption of 100%
polyphenol-rich Concord grape juice did not cause significant weight gain,...
Resurgent Health and Medical Announces That Children's Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems
Hospital makes proactive choice to elevate hand hygiene measures for patients, staff and visitors
GOLDEN, Colo. and MINNEAPOLIS, Sept. 30 /PRNewswire/ -- Resurgent
Health and Medical, a leader in automated handwashing and sanitizing
technology, announced today that Child...
New Bisphenol A Study Has Limited Capability to Assess Human Health Effects
ARLINGTON, Va., Sept. 16 /PRNewswire-USNewswire/ -- The American
Chemistry Council is aware of a new study on bisphenol A published today in
the Journal of the American Medical Association that reports a statistical
association between urinary bisphenol A concentrations and medical
Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia
PALO ALTO, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Jazz
Pharmaceuticals, Inc. (Nasdaq: JAZZ ) today announced that the final patient
has completed participation in the first Phase III pivotal clinical trial
of JZP-6 (sodium oxybate) for the treatment of fibromyalgia.
The JZP-6 Phase III ...
The First Direct Structural Evidence of SV2A has Been Revealed Thanks to Protein Tomography(TM), and Published in BBRC
Summary: Protein Tomography(TM) has
yet Again Provided Structural Proof of
a Drug Target Function. A Study Performed by Sidec and UCB, Characterizes
the Target of Anti-Epileptic Drug in Situ Where Two Major Conformations Have Been Identified
STOCKHOLM, September 9 /P...
Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
HONG KONG, July 7 /PRNewswire/ -- OrbusNeich today announced that data
presented recently at the 17th Annual Meeting of the Japanese Society of
Interventional Cardiology demonstrate that the Genous Bio-engineered R
better outcomes when compared to drug-eluting stents.
Presented by ...
Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD)
GREEN BAY, Wis., May 15 /PRNewswire/ -- Omega 3 fatty acids bound to
phospholipids deserves to be further considered as a credible natural
alternative and may have beneficial effect on impulsivity in ADHD patients,
recent in vivo French study reveals. While several studies have reported
Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care
NEWPORT NEWS, Va., April 29 /PRNewswire/ -- Recently published data in
The American Journal of Surgery by a group of surgeons from Legacy Good
Samaritan Hospital in Portland, Oregon, demonstrates the value of using
Breast-Specific Gamma Imaging (BSGI) for the clinical management of breast
Summit VetPharm has Identified Two Instances of Diverted Vectra 3D(TM)
FT. LEE, N.J., Feb. 4 /PRNewswire/ -- This week, Summit VetPharm has
identified two instances where its veterinary exclusive Vectra 3D(TM)
been found on the websites of internet pharmacies, which is in
clear violation of the Company's anti-diversion policy.
"I am very disappointe...
OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial
NAPLES, Italy, Jan. 10 /PRNewswire/ -- Patients who received
OrbusNeich's pro-healing stent, the Genous Bio-engineered R stent, had
significantly fewer major cardiac adverse events (MACE) than patients who
received Boston Scientific's TAXUS or Johnson & Johnson's CYPHER
drug-eluting stents in ...
Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
- NEXIUM(R) (esomeprazole magnesium) Proven Effective at Standard Doses Regardless of Body Mass Index -
PHILADELPHIA, Oct. 16 /PRNewswire-FirstCall/ -- The link between
gastroesophageal reflux disease (GERD) and obesity has
established, but healthcare professionals...
New Study Shows Concord Grape Juice has a Heart-Healthy Effect not yet Reported With Red Wine
CONCORD, Mass., Oct. 2 /PRNewswire/ -- Many studies have suggested that
moderate red wine consumption is beneficial to cardiovascular health. But
what if you'd like to skip the alcohol? Take heart: laboratory research,
just presented at the WINEHEALTH 2007 conference in Bordeaux, France,
New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
CAIRNS, Australia, Aug. 31 /PRNewswire/ -- What and When Data from a six-month study of ramelteon will be presented in poster
format at worldsleep07: The 5th World Congress of the World Federation of
Sleep Research and Sleep Medicine Societies to be held in Cairns, Australia
September 2-6, 2...
Replikins LLC Finds West Nile Virus Replikin Count Has Reached Its Highest Recorded Value
BOSTON, Aug. 3 /PRNewswire/ -- Replikins LLC has
discovered a new group
of virus structural peptides within virus proteins, called replikins, which
provide virus-specific advance quantitative warnings of rapid replication
and the risk of epidemics. Replikins LLC has
developed software called
Nearly 1 in 10 Americans Has A Relative With Kidney Failure
African-Americans with Family History of ESRD Are at High
WASHINGTON, March 9, 2007 - Approximately ten percent of U.S.
adults have a family history of end-stage renal disease (ESRD), and
these individuals appear to be at increased risk of developing
kidney disease themselves, reports a ...
Oncolytics Biotech Inc. Research Collaborators Demonstrate
Reovirus/Gemcitabine Combination Has Synergistic Effect Against
Human Colon Cancer Cell Lines
CALGARY, April 17, 2007 /PRNewswire-FirstCall/ - Oncolytics
Biotech Inc. ("Oncolytics") announces that a poster by Dr. Maureen
E. Lane et al. of , New York, entitled "In Vivo Synergy between
Oncolytic Reovirus and Gemcitabine in Ras-Mutated Human HCT116
Xenografts" is scheduled to be presented tod...
Onconase has Potential as Chemopreventive Agent in Mesothelioma,
Reports World-Renowned Mesothelioma Researcher at AACR Annual
BLOOMFIELD, N.J., April 18, 2007 /PRNewswire-FirstCall/ --
ONCONASE (ranpirnase), Alfacell Corporation's lead drug candidate,
may have potential as a chemopreventive agent, according to
world-renowned mesothelioma researcher Michele Carbone M.D., Ph.D.,
at this week's American Association for Canc...
Repros Reports That Proellex Has Demonstrated Superior Efficacy and
Safety in Endometriosis When Compared to Standard of Drug Care
THE WOODLANDS, Texas--(BUSINESS WIRE)--Jun 11, 2007 - Repros
Therapeutics Inc. (NasdaqGM:RPRX) today released top-line findings
from its six month study of Proellex in the treatment of
endometriosis. This study, conducted in Europe, enrolled 39
premenopausal women and has
completed six months of do...
New Study Shows That telmisartan has Greater Renoprotective
Potential Thanlosartan in Hypertensive Patients With Type 2
MILAN, Italy, June 15 /CNW/ - Today AMADEO, one of the
first studies to compare the protective potential of two
angiotensin receptor blockers in hypertensive patients with
diabetic nephropathy, was presented at the European Society
of Hypertension, Milan. The results from this study show that ...
Dean: President Bush Has Turned His Back on the American People
WASHINGTON, June 20, 2007 /PRNewswire-USNewswire/ -- Democratic
National Committee Chairman Howard Dean issued the following
statement today after President Bush once again put politics ahead
of science by vetoing the Stem Cell Research Enhancement Act of
The legislation, providing federal...
Common Preterm Labor Drug Has More Side Effects Than Alternative,
Finds Study from Packard Children's Hospital and Stanford
STANFORD, Calif.--(BUSINESS WIRE)--Jun 29, 2007 - The drug most
commonly used to arrest preterm labor, magnesium sulfate, is more
likely than another common treatment to cause mild to serious side
effects in pregnant women, according to a study from researchers at
Lucile Packard Children's Hospital...
Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases
...hat are considered to be among today's finest resources for diagnosis, treatment and research.
Founded in 1901, Children's Hospital Los Angeles has
been treating the most seriously ill and injured children in Los Angeles for more than a century, and it is acknowledged throughout the United States ...
Regular Yoga Practice Is Associated With Mindful Eating
...ng yoga practice to a standard weight-loss program may make it more effective," said Kristal, who himself scored high on the mindful-eating survey and has
a BMI within the normal range.
Moving forward, Kristal and colleagues suggest that their Mindful Eating Questionnaire, the first tool of its ki...
Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
...g. 7 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY ), announced today the company has
submitted to the U.S. Food and Drug Administration (FDA) a supplemental application for licensure of its influenza A(H1N1) 2009 monovalent vaccine. Re...
Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
...always turned "on," regardless of whether the EGFR has
been activated or therapeutically inhibited. KRAS...toms or increased survival with Vectibix. Vectibix has
not shown a treatment benefit for patients whose t...ailure of standard chemotherapy regimens. Vectibix has
been launched in over 20 countries, Switzerland, A...
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
...the quarter ended June 30, 2009. During 2009 Isis has
continued to successfully execute its business str...ional drugs into development in 2009; one new drug has
already moved into development this year
...lts as discontinued operations. Accordingly, Isis has
presented all periods of Ibis' operating results i...
Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
...le Diabetes Research Foundation said today that it has
entered into a novel collaborative research agreem... With a team of 550 scientists and associates, it has
an impressive track record of success in translational research, and has
contributed significantly to Novartis' pipeline of...
Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors
...ncer Centers of North Carolina
Cancer Centers of North Carolina (CCNC) has
been providing comprehensive cancer care in the greater Triangle area for 3...ngle physician practice, originally named Raleigh Hematology Oncology, CCNC has
grown to a physician staff of thirteen medical oncologists, two radiation o...
SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite
...em working in all geographies in which the company has
SIRO Clinphar...maceutical companies across the world. The company has
offices in India, USA, Israel and in Germany, Romania, Estonia and Greece. SIRO has
recently opened offices in Czech Republic & Sp...
Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
...related protein). In Phase I and II studies, BA058 has
demonstrated the potential to widen the anabolic w...refilled cartridge presentation for self-injection has
demonstrated long-term stability at room temperatu...e-mineral density. A 50-year-old woman in the U.S. has
a 40 percent lifetime risk of osteoporotic fractur...
NewCardio Announces Master Services Agreement With Dedicated Phase I
...Phase I, an innovative, Phoenix, Arizona-based provider of clinical research services including a Core ECG laboratory for Thorough QT and QTc studies, has
signed a Master Services Agreement (MSA) with NewCardio. Under terms of this agreement, Dedicated Phase I will receive a license to use NewCardio's QT...